Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000513330 | SCV000528238 | benign | not provided | 2019-09-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24895405) |
Ce |
RCV000513330 | SCV000608788 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4 |
Eurofins Ntd Llc |
RCV000438008 | SCV000704115 | benign | not specified | 2016-12-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000513330 | SCV002371162 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002244912 | SCV002514312 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279195 | SCV002565403 | likely benign | Ehlers-Danlos syndrome | 2022-02-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002393012 | SCV002674313 | benign | Cardiovascular phenotype | 2019-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000438008 | SCV001809147 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000513330 | SCV001975894 | likely benign | not provided | no assertion criteria provided | clinical testing |